Differentiation-specific factors modulate epidermal CYP1-4 gene expression in human skin in response to retinoic acid and classic aryl hydrocarbon receptor ligands

Journal of Pharmacology and Experimental Therapeutics

Volumn 319, Issue 3, 2006, Pages 1162-1171

  Du, Liping ^a   Neis, Mark M ^b   Ladd, Patricia A ^a   Keeney, Diane S ^a,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; BETA NAPHTHOFLAVONE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; CYTOCHROME P450 2C18; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 2J2; CYTOCHROME P450 2S1; CYTOCHROME P450 2U1; CYTOCHROME P450 2W1; CYTOCHROME P450 3A4; CYTOCHROME P450 4B1; CYTOKERATIN 10; DAPSONE; DEXAMETHASONE; DRUG METABOLIZING ENZYME; LIGAND; MESSENGER RNA; MICONAZOLE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; RESVERATROL; RETINOIC ACID; RIFAMPICIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; CROSS LINKING; DRUG EXPOSURE; DRUG INHIBITION; EPIDERMIS; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SKIN; UPREGULATION;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CROSS-LINKING REAGENTS; CYTOCHROME P-450 ENZYME SYSTEM; FACTOR XIIIA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFANT, NEWBORN; KERATINOCYTES; MALE; RECEPTORS, ARYL HYDROCARBON; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; TETRACHLORODIBENZODIOXIN; TRANSCRIPTION FACTOR AP-1; TRETINOIN; UP-REGULATION;

EID: 33751195546     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.111724     Document Type: Article

References (40)

1. Ahmad N and Mukhtar H (2004) Cytochrome P450: a target for drug development for skin diseases. J Investig Dermatol 123:417-425.
2. Andreola F, Hayhurst GP, Luo G, Ferguson SS, Gonzalez FJ, Goldstein JA, and De Luca LM (2004) Mouse liver CYP2C39 is a novel retinoic acid 4-hydroxylase. Its down-regulation offers a molecular basis for liver retinoid accumulation and fibrosis in aryl hydrocarbon receptor-null mice. J Biol Chem 279:3434-3438.
3. Angel P, Szabowski A, and Schorpp-Kistner M (2001) Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene 20:2413-2423.
4. Baron JM, Heise R, Blaner WS, Neis M, Joussen S, Dreuw A, Marquardt Y, Saurat JH, Merk HF, Bickers DR, et al. (2005) Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Investig Dermatol 125:143-153.
5. Berkers JA, Hassing I, Spenkelink B, Brouwer A, and Blaauboer BJ (1995) Interactive effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and retinoids on proliferation and differentiation in cultured human keratinocytes: quantification of cross-linked envelope formation. Arch Toxicol 69:368-378.
6. Bock KW and Kohle C (2006) Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem Pharmacol 72:393-404.
7. Crow KD and Puhvel SM (1991) Chloracne (halogen acne), in Dermatotoxicology (Marzulli FN and Maibach HI eds) pp 647-665, Hemisphere Publishing Corporation, New York.
8. Du L, Neis MM, Ladd PA, Lanza DL, Yost GS, and Keeney DS (2006) Effects of the differentiated keratinocyte phenotype on expression levels of CYP1-4 family genes in human skin cells. Toxicol Appl Pharmacol 213:135-144.
9. Fisher GJ and Voorhees JJ (1996) Molecular mechanisms of retinoid actions in skin. FASEB J 10:1002-1013.
10. Gibson DF, Ratnam AV, and Bikle DD (1996) Evidence for separate control mechanisms at the message, protein, and enzyme activation levels for transglutaminase during calcium-induced differentiation of normal and transformed human keratinocytes. J Investig Dermatol 106:154-161.
11. Guengerich FP (2006) Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J 8:E101-E111.
12. Harper PA, Riddick DS, and Okey AB (2006) Regulating the regulator: factors that control levels and activity of the aryl hydrocarbon receptor Biochem Pharmacol 72:267-279.
13. Hoffer A, Chang CY, and Puga A (1996) Dioxin induces transcription of fos and jun genes by Ah receptor-dependent and -independent pathways. Toxicol Appl Pharmacol 141:238-247.
14. Jones CL and Reiners JJ Jr (1997) Differentiation status of cultured murine keratinocytes modulates induction of genes responsive to 2,3,7,8-tetrachlorodibenzo-pdioxin. Arch Biochem Biophys 347:163-173.
15. Kohle C and Bock KW (2006) Activation of coupled Ah receptor and Nrf2 gene batteries by dietary phytochemicals in relation to chemoprevention. Biochem Pharmacol 72:795-805.
16. Ladd PA, Du L, Capdevila JH, Mernaugh R, and Keeney DS (2003) Epoxyeicosatrienoic acids activate transglutaminases in situ and induce cornification of epidermal keratinocytes. J Biol Chem 278:35184-35192.
17. Lee ZW, Kwon SM, Kim SW, Yi SJ, Kim YM, and Ha KS (2003) Activation of in situ tissue transglutaminase by intracellular reactive oxygen species. Biochem Biophys Res Commun 305:633-640.
18. Levin W, Conney AH, Alvares AP, Merkatz I, and Kappas A (1972) Induction of benzo(a)pyrene hydroxylase in human skin. Science (Wash DC) 176:419-420.
19. Loertscher JA, Sattler CA, and Allen-Hoffmann BL (2001) 2,3,7,8-Tetrachlorodibenzo-p-dioxin alters the differentiation pattern of human keratinocytes in organotypic culture. Toxicol Appl Pharmacol 175:121-129.
20. Lorand L and Graham RM (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 4:140-156.
21. Marill J, Cresteil T, Lanotte M, and Chabot GG (2000) Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol 58:1341-1348.
22. Mehic D, Bakiri L, Ghannadan M, Wagner EF, and Tschachler E (2005) Fos and jun proteins are specifically expressed during differentiation of human keratinocytes. J Investig Dermatol 124:212-220.
23. Merk HF, Abel J, Baron JM, and Krutmann J (2004) Molecular pathways in dermatotoxicology. Toxicol Appl Pharmacol 195:267-277.
24. Murphy KA, Villano CM, Dorn R, and White LA (2004) Interaction between the aryl hydrocarbon receptor and retinoic acid pathways increases matrix metalloproteinase-1 expression in keratinocytes. J Biol Chem 279:25284-25293.
25. Nelson DR, Zeldin DC, Hoffman SMG, Maltais LJ, Wain HM, and Nebert DW (2004) Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14:1-18.
26. Parkinson A, Mudra DR, Johnson C, Dwyer A, and Carroll KM (2004) The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes. Toxicol Appl Pharmacol 199:193-209.
27. Phillips MA, Jessen BA, Lu Y, Qin Q, Stevens ME, and Rice RH (2004) A distal region of the human TGM1 promoter is required for expression in transgenic mice and cultured keratinocytes. BMC Dermatol 4:2.
28. Puga A, Hoffer A, Zhou S, Bohm JM, Leikauf GD, and Shertzer HG (1997) Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem Pharmacol 54:1287-1296.
29. Puhvel SM, Ertl DC, and Lynberg CA (1984) Increased epidermal transglutaminase activity following 2,3,7,8-tetrachlorodibenzo-p-dioxin: in vivo and in vitro studies with mouse skin. Toxicol Appl Pharmacol 73:42-47.
30. Rea MA, Gregg JP, and Rice RH (2002) Expression profiling of TCDD-treated human epidermal cells in culture. Organohalogen Comp 55:469-472.
31. Rossi A, Jang SI, Ceci R, Steinert PM, and Markova NG (1998) Effect of AP1 transcription factors on the regulation of transcription in normal human epidermal keratinocytes. J Investig Dermatol 110:34-40.
32. Roujeau JC (2005) Clinical heterogeneity of drug hypersensitivity. Toxicology 209:123-129.
33. Roychowdhury S, Vyas PM, Reilly TP, Gaspari AA, and Svensson CK (2005) Characterization of the formation and localization of sulfamethoxazole and dapsone-associated drug-protein adducts in human epidermal keratinocytes. J Pharmacol Exp Ther 314:43-52.
34. Saarikoski ST, Rivera SP, Hankinson O, and Husgafvel-Pursiainen K (2005) CYP2S1: a short review. Toxicol Appl Pharmacol 207:62-69.
35. Santostefano M, Merchant M, Arellano L, Morrison V, Denison MS, and Safe S (1993) α-Naphthoflavone-induced CYP1A1 gene expression and cytosolic aryl hydrocarbon receptor transformation. Mol Pharmacol 43:200-206.
36. Swanson HI (2004) Cytochrome P450 expression in human keratinocytes: an aryl hydrocarbon receptor perspective. Chem Biol Interact 149:69-79.
37. Tanaka E (1998) Clinically important pharmacokinetic drug-drug interactions: role of cytochrome P450 enzymes. J Clin Pharm Ther 23:403-416.
38. Tsankov N and Angelova I (2003) Rifampin in dermatology. Clin Dermatol 21:50-55.
39. Wolf R, Tuzun B, and Tuzun Y (2000) Dapsone: unapproved uses or indications. Clin Dermatol 18:37-53.
40. Yamamoto O and Tokura Y (2003) Photocontact dermatitis and chloracne: two major occupational and environmental skin diseases induced by different actions of halogenated chemicals. J Dermatol Sci 32:85-94.